ZA200804083B - Bi-aryl meta-pyrimidine inhibitors of kinases - Google Patents

Bi-aryl meta-pyrimidine inhibitors of kinases

Info

Publication number
ZA200804083B
ZA200804083B ZA200804083A ZA200804083A ZA200804083B ZA 200804083 B ZA200804083 B ZA 200804083B ZA 200804083 A ZA200804083 A ZA 200804083A ZA 200804083 A ZA200804083 A ZA 200804083A ZA 200804083 B ZA200804083 B ZA 200804083B
Authority
ZA
South Africa
Prior art keywords
kinases
pyrimidine inhibitors
aryl meta
meta
aryl
Prior art date
Application number
ZA200804083A
Inventor
Cao Jon Jianguo
Hood John
Lohse Dan
Mak Chi Ching
Mcpherson Andrew Noronha Glenn
Pathak Ved
Renick Joel
Richard M Soll
Zeng Binqi
Original Assignee
Targegen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targegen Inc filed Critical Targegen Inc
Publication of ZA200804083B publication Critical patent/ZA200804083B/en

Links

ZA200804083A 2005-11-01 2006-10-26 Bi-aryl meta-pyrimidine inhibitors of kinases ZA200804083B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73262905P 2005-11-01 2005-11-01

Publications (1)

Publication Number Publication Date
ZA200804083B true ZA200804083B (en) 2009-09-30

Family

ID=40413957

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804083A ZA200804083B (en) 2005-11-01 2006-10-26 Bi-aryl meta-pyrimidine inhibitors of kinases

Country Status (3)

Country Link
CN (1) CN101370792B (en)
UA (3) UA109411C2 (en)
ZA (1) ZA200804083B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120114355A (en) * 2010-01-13 2012-10-16 글락소스미스클라인 엘엘씨 Compounds and methods
WO2012060847A1 (en) * 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
CN103242240B (en) * 2012-02-10 2016-01-06 上海温康化学研发有限公司 A kind of intermediate, its salt and preparation method thereof of sulfamide compound
CN105796562A (en) * 2012-09-10 2016-07-27 杨子娇 Application of compound to preparation of drug for preventing and treating glaucoma
CN103664798A (en) * 2012-09-20 2014-03-26 杨育新 Compounds for treating traumatic brain injury diseases and application thereof
CN103664799A (en) * 2012-09-25 2014-03-26 杨子娇 Compounds for treating narrow chamber angle and application thereof
CN103664907A (en) * 2012-09-25 2014-03-26 杨子娇 Compounds for treating narrow chamber angle and application thereof
CN103724331A (en) * 2012-10-11 2014-04-16 韩冰 Compound for treating cerebral palsy and use thereof
EP2970205B1 (en) * 2013-03-14 2019-05-08 Tolero Pharmaceuticals, Inc. Jak2 and alk2 inhibitors and methods for their use
RS57662B1 (en) * 2013-12-11 2018-11-30 Biogen Ma Inc Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
CN103992262B (en) * 2014-06-12 2015-11-11 苏州明锐医药科技有限公司 Sai Rui replaces the preparation method of Buddhist nun and intermediate thereof
CN106188063A (en) * 2015-05-08 2016-12-07 中国科学院上海药物研究所 As Lp-PLA2dicyclo compounds, its preparation method and the medical usage of inhibitor
CN108689949A (en) * 2018-07-02 2018-10-23 湖南华腾制药有限公司 A kind of pyridine derivatives and preparation method thereof
CN110305140B (en) 2019-07-30 2020-08-04 上海勋和医药科技有限公司 Dihydropyrrolopyrimidines selective JAK2 inhibitors
US20220402948A1 (en) * 2019-09-26 2022-12-22 Betta Pharmaceuticals Co., Ltd. Egfr inhibitor, composition and preparation method therefor
US20240108633A1 (en) * 2020-12-29 2024-04-04 Onquality Pharmaceuticals China Ltd. Method for preventing or treating disease or condition associated with antitumor agent
AU2021416682B2 (en) * 2021-01-11 2024-01-11 Guangzhou Salustier Biosciences Co., Ltd. 2-aminopyrimidine compound and pharmaceutical composition thereof and application thereof
CN112920124B (en) * 2021-01-29 2024-03-01 安徽医科大学 Pyrimidine-2, 4-diamine compound, and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004887D0 (en) * 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds

Also Published As

Publication number Publication date
CN101370792B (en) 2013-03-20
UA109412C2 (en) 2015-08-25
CN101370792A (en) 2009-02-18
UA99899C2 (en) 2012-10-25
UA109411C2 (en) 2015-08-25

Similar Documents

Publication Publication Date Title
HUS2100020I1 (en) Bi-aryl meta-pyrimidine inhibitors of kinases
ZA200804083B (en) Bi-aryl meta-pyrimidine inhibitors of kinases
HRP20181622T1 (en) Imidazotriazines and imidazopyrimidines as kinase inhibitors
HK1225722A1 (en) Inhibitors of kinase activity
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
EP1893607A4 (en) Inhibitors of checkpoint kinases
EP2166846A4 (en) Inhibitors of janus kinases
EP2231143A4 (en) Inhibitors of janus kinases
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
ZA200704106B (en) Inhibitors of c-fms kinase
HK1129298A1 (en) Dihydrodiazepines useful as inhibitors of protein kinases
EP2278969A4 (en) Inhibitors of janus kinases
EP2299816A4 (en) Inhibitors of janus kinases
ZA200802685B (en) Deazapurines useful as inhibitors of janus kinases
ZA200809873B (en) Inhibitors of c-fms kinase
IL194699A0 (en) Tetrahydropteridines useful as inhibitors of protein kinases
EP2310384A4 (en) Inhibitors of janus kinases
EP2200612A4 (en) Inhibitors of janus kinases
ZA200806871B (en) Dihydrodiazepines useful as inhibitors of protein kinases
GB0608823D0 (en) Inhibitors of P13 kinase
EP2341775A4 (en) Inhibitors of janus kinases
EP2032141A4 (en) Inhibitors of janus kinases
IL182735A0 (en) Inhibitors of c-fms kinase
EP1904449A4 (en) Inhibitors of checkpoint kinases